The Quantellect read.As of Nov 19, 2026, 3 active firms cover InMode Ltd: 1 rate it Buy or better, 2 sit at Neutral, and 0 rate it Sell or worse, a neutral consensus. Targets are tightly clustered, $14.00 to $19.00, so the covering firms are broadly aligned. The average target of $16.00 sits 24% above the current $12.88. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.28 next quarter toward $1.36 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 active firms
Neutral
Strong Buy00%
Buy133%
Neutral267%
Sell00%
Strong Sell00%
Based on 3 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$16.00
+24.2% upside
Average target across 3 active firms as of Nov 19, 2026 vs $12.89 current
Highest Target$19.00
Average Target$16.00
Lowest Target$14.00
Detailed analyst forecasts for INMD
Showing 1–3 of 3 named analysts shown · 3 active firms in the rating projection
As of Nov 19, 2026, 1 of 3 active firms rate INMD a Buy (2 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
INMD EPS & revenue forecast
EPS · NEXT QUARTER
$0.28
Range $0.25 – $0.30 · 4 analysts · +11% YoY
Next period, 4 analysts expect InMode Ltd to earn $0.28 a share (range $0.25 – $0.30), versus $0.25 a year earlier. Full-year consensus is $1.32, growing to $1.36 the year after.
REVENUE · NEXT QUARTER
$82.0M
Range $80.3M – $83.2M · 4 analysts · +0% YoY
Revenue is expected to reach $82.0M (range $80.3M – $83.2M), +0.0% year-over-year. Full-year consensus is $370.1M, rising to $376.2M next year.
Top analysts covering InMode Ltd
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on INMD.
#1
CC
Caitlin Cronin
Canaccord Genuity · Rank #260
Neutral
$15.00+16.4% to target
Overall win rate
39%
+ Follow
#2
Mike Matson
Needham · Rank #285
Neutral
No targeton INMD
Overall win rate
36%
+ Follow
#3
Matt Miksic
Barclays · Rank #543
Buy
$19.00+47.5% to target
Overall win rate
27%
+ Follow
#4
Danielle Antalffy
UBS
Neutral
$16.00+24.2% to target
Coverage
—
+ Follow
#5
SE
Sam Eiber
BTIG
Neutral
No targeton INMD
Coverage
—
+ Follow
INMD stock forecast FAQ
What is INMD's average 12-month price target?+
The 3 active firms with a live target average $16.00 for InMode Ltd over the next 12 months, ranging from a $19.00 high to a $14.00 low, as of Nov 19, 2026.
Is INMD stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 3 active firms as of Nov 19, 2026, 1 rate it Buy or Strong Buy, 2 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for INMD?+
The Street-high target is $19.00 (Barclays), and the Street-low is $14.00 (Baird). The average of all 3 active-firm targets is $16.00.
How many active Wall Street firms cover INMD?+
3 active firms have a recognized rating on InMode Ltd as of Nov 19, 2026, and 3 active firms carry a live 12-month price target.
Who is the most accurate analyst covering INMD?+
Among analysts who currently cover INMD, Caitlin Cronin of Canaccord Genuity has the strongest overall Quantellect track record (Rank #260). Their current call is Neutral with a $15.00 target.
What is InMode Ltd's projected EPS for next quarter?+
The consensus estimate is $0.28 per share (range $0.25 – $0.30) across 4 analysts. Full-year EPS is projected at $1.32, rising to $1.36 the following year.
How much revenue is InMode Ltd expected to report next quarter?+
Consensus revenue is $82.0M (range $80.3M – $83.2M). Full-year revenue is projected at $370.1M, growing to $376.2M next year.
Have analysts been upgrading or downgrading INMD lately?+
As of Nov 19, 2026, 1 of 3 active firms rate INMD a Buy (2 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their INMD calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.